Figure 6.
Figure 6. Treatment of RAS-mutated H929 cells demonstrates down-regulation of MIP-1 α by flow cytometric assessment following treatment with the ERK pathway inhibitor PD98059 (10 μM) at 48 hours. Gray line indicates drug treated; and the solid black line, untreated cells stained for MIP-1α expression. Experiments were performed twice with similar results; a representative experiment is shown here.

Treatment of RAS-mutated H929 cells demonstrates down-regulation of MIP-1 α by flow cytometric assessment following treatment with the ERK pathway inhibitor PD98059 (10 μM) at 48 hours. Gray line indicates drug treated; and the solid black line, untreated cells stained for MIP-1α expression. Experiments were performed twice with similar results; a representative experiment is shown here.

Close Modal

or Create an Account

Close Modal
Close Modal